Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

1,734 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,734 results

Large-scale testing (Phase 3)Study completedNCT00054717
What this trial is testing

Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)

Who this might be right for
HIV Infections
Boehringer Ingelheim 630
Early research (Phase 1)Study completedNCT00002321
What this trial is testing

A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Chiron Corporation
Not applicableStudy completedNCT01541085
What this trial is testing

An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART

Who this might be right for
Human Immunodeficiency Virus; HIV
Janssen-Cilag S.p.A. 33
Not applicableStudy completedNCT01667978
What this trial is testing

The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception

Who this might be right for
PregnancyHIVAIDS
University of Southern California 35
Testing effectiveness (Phase 2)Study completedNCT00654147
What this trial is testing

Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects

Who this might be right for
HIV Infections
Margaret A. Fischl, M.D. 44
Early research (Phase 1)UnknownNCT00002449
What this trial is testing

Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy

Who this might be right for
HIV Infections
Chiron Corporation 212
Post-approval studies (Phase 4)Study completedNCT03087890
What this trial is testing

Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria

Who this might be right for
HIV-1-infectionPneumocystis PneumoniaOpportunistic Infections+2 more
University of Bergen 537
Not applicableStudy completedNCT00106678
What this trial is testing

Typology of Adherence in Adolescents: Phase II

Who this might be right for
HIV Infection
University of North Carolina, Chapel Hill 1,200
Testing effectiveness (Phase 2)Study completedNCT00002171
What this trial is testing

Viracept in HIV-Positive Women

Who this might be right for
HIV Infections
Agouron Pharmaceuticals
Not applicableNot Yet RecruitingNCT07015164
What this trial is testing

Role of Viral Reservoir, Immune Activation and Depletion in Persistent Viremia Persistent Viremia in People Living With HIV on Antiretroviral Therapy

Who this might be right for
HIV
Assistance Publique - Hôpitaux de Paris 80
Not applicableUnknownNCT04858243
What this trial is testing

Engaging Men Through HIV Self-Testing With Differentiated Care to Improve ART Initiation and Viral Suppression Among Men in Malawi

Who this might be right for
Hiv
University of California, Los Angeles 930
Not applicableStudy completedNCT02407691
What this trial is testing

Collaborative Care for the Detection and Management of Depression Among Adults Receiving Antiretroviral Therapy in South Africa

Who this might be right for
HIV/AIDSDepressionChronic Diseases of Lifestyle
University of Cape Town 2,002
Post-approval studies (Phase 4)Ended earlyNCT00122668
What this trial is testing

Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients

Who this might be right for
HIV InfectionsHIV-Associated Lipodystrophy Syndrome
French National Agency for Research on AIDS and Viral Hepatitis 112
Testing effectiveness (Phase 2)Ended earlyNCT00090779
What this trial is testing

Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV

Who this might be right for
HIV Infections
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 130
Early research (Phase 1)Study completedNCT02018510
What this trial is testing

A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117

Who this might be right for
HealthyHIV
Rockefeller University 49
Not applicableStudy completedNCT00238459
What this trial is testing

Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 58
Not applicableStudy completedNCT00941876
What this trial is testing

Integration of Family Planning and HIV Services in Tanzania

Who this might be right for
HIV InfectionHIV Infections
FHI 360 864
Not applicableWithdrawnNCT04468789
What this trial is testing

Evaluation of Six-month HIV Treatment Dispensing in South Africa

Who this might be right for
HIV
Boston University
Large-scale testing (Phase 3)Study completedNCT00046176
What this trial is testing

A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 240
Large-scale testing (Phase 3)Study completedNCT01227824
What this trial is testing

A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily

Who this might be right for
Infection, Human Immunodeficiency Virus I
ViiV Healthcare 828
Next Page